2021. Oral lipid formulation type IV as an approach in the formulation of solid dosage forms with poorly soluble substances: Chremophor®RH 40 as a surfactant phase. Progress in Nutrition. 23, 3 (Oct. 2021), e2021279. DOI:https://doi.org/10.23751/pn.v23i3.12071.